Finding the Best Clinical Trial

November 25, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Finding the Best Clinical Trial

I'm glad you're exploring clinical trials—they can offer access to innovative treatments and close monitoring by research teams. Here's how to approach this systematically:


Understanding Clinical Trials

Clinical trials test new cancer treatments to see if they're safe and effective. They're organized by phases:

  • Phase 1: Tests safety and dosage in small groups
  • Phase 2: Tests effectiveness and side effects in larger groups
  • Phase 3: Compares new treatment to standard treatment
  • Phase 4: Monitors long-term effects after FDA approval

Where to Search for Trials

Authoritative Trial Databases:

  1. ClinicalTrials.gov (National Institutes of Health)

    • Search by cancer type, location, and treatment type
    • Shows trial status, eligibility criteria, and contact information
    • Most comprehensive U.S. database
  2. Cancer.gov Clinical Trials Search (National Cancer Institute)

    • NCI-specific trials with detailed descriptions
    • Includes basic and advanced search options
  3. NCCN Member Institutions

    • National Comprehensive Cancer Network lists trials at major cancer centers
    • Often have cutting-edge research programs
  4. Your Hospital/Cancer Center

    • Ask your oncologist about trials they're running or know about
    • Many centers have trial coordinators to help match patients

Key Questions to Ask About Any Trial

✓ What is the trial testing, and how does it differ from standard treatment?

✓ What phase is this trial in, and what does that mean for safety?

✓ What are the eligibility requirements, and do I qualify?

✓ What are the potential benefits AND risks/side effects?

✓ How often will I need to visit, and what tests are involved?

✓ Will the trial be free, or will I have costs?

✓ Can I leave the trial if I want to?

✓ Who is the principal investigator, and how experienced is the team?

✓ How will my progress be monitored?


Evaluating Trial Fit

Consider these factors:

  • Does the trial match your cancer type and stage?
  • Are you physically able to meet the time/travel requirements?
  • Does the treatment approach align with your values and goals?
  • Is the research institution reputable and experienced?
  • What's the trial's track record so far (if available)?

Working With Your Oncologist

Your doctor should:

  • Help identify trials appropriate for YOUR specific situation
  • Explain how a trial compares to standard treatment options
  • Discuss potential benefits and risks for YOUR case
  • Help you understand informed consent documents

Red flags: Be cautious of trials that:

  • Pressure you to decide quickly
  • Don't clearly explain risks
  • Aren't registered on ClinicalTrials.gov
  • Lack experienced research teams

Additional Resources

  • American Cancer Society: cancer.org/research/clinical-trials
  • Cancer Support Community: cancersupportcommunity.org
  • Your hospital's research department or trial coordinator

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2